Targeting transmembrane TNF-α suppresses breast cancer growth
- PMID: 23794706
- DOI: 10.1158/0008-5472.CAN-12-3946
Targeting transmembrane TNF-α suppresses breast cancer growth
Abstract
TNF antagonists may offer therapeutic potential in solid tumors, but patients who have high serum levels of TNF-α fail to respond to infliximab, suggesting consumption of the circulating antibody and loss of transmembrane TNF-α (tmTNF-α) on tumors by ectodomain shedding. Addressing this possibility, we developed a monoclonal antibody (mAb) that binds both full-length tmTNF-α and its N-terminal truncated fragment on the membrane after tmTNF-α processing but does not cross-react with soluble TNF-α. We documented high levels of tmTNF-α expression in primary breast cancers, lower levels in atypical hyperplasia or hyperplasia, but undetectable levels in normal breast tissue, consistent with the notion that tmTNF-α is a potential therapeutic target. Evaluations in vitro and in vivo further supported this assertion. tmTNF-α mAb triggered antibody-dependent cell-mediated cytotoxicity against tmTNF-α-expressing cells but not to tmTNF-α-negative cells. In tumor-bearing mice, tmTNF-α mAb delayed tumor growth, eliciting complete tumor regressions in some mice. Moreover, tmTNF-α mAb inhibited metastasis and expression of CD44v6, a prometastatic molecule. However, the antibody did not activate tmTNF-α-mediated reverse signaling, which facilitates tumor survival and resistance to apoptosis, but instead inhibited NF-κB activation and Bcl-2 expression by decreasing tmTNF-α-positive cells. Overall, our results established that tmTNF-α mAb exerts effective antitumor activities and offers a promising candidate to treat tmTNF-α-positive tumors, particularly in patients that are nonresponders to TNF antagonists.
©2013 AACR.
Similar articles
-
Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha.Breast Cancer Res Treat. 2009 Jul;116(1):91-102. doi: 10.1007/s10549-008-0111-5. Epub 2008 Jul 10. Breast Cancer Res Treat. 2009. PMID: 18618239
-
Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.Oncogene. 2018 Jun;37(25):3456-3470. doi: 10.1038/s41388-018-0221-4. Epub 2018 Mar 21. Oncogene. 2018. PMID: 29559745 Free PMC article.
-
Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.J Immunol. 2014 Feb 1;192(3):1320-31. doi: 10.4049/jimmunol.1203195. Epub 2013 Dec 30. J Immunol. 2014. PMID: 24379122
-
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers.J Immunother Cancer. 2023 Jan;11(1):e003837. doi: 10.1136/jitc-2021-003837. J Immunother Cancer. 2023. PMID: 36720496 Free PMC article.
-
Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer.Curr Pharm Biotechnol. 2016;17(6):486-94. doi: 10.2174/1389201017666160301102713. Curr Pharm Biotechnol. 2016. PMID: 26927216 Review.
Cited by
-
Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy.Cancer Biol Ther. 2016 Jun 2;17(6):684-92. doi: 10.1080/15384047.2016.1187551. Cancer Biol Ther. 2016. PMID: 27224726 Free PMC article.
-
Knockout of the Tnfa Gene Decreases Influenza Virus-Induced Histological Reactions in Laboratory Mice.Int J Mol Sci. 2024 Jan 18;25(2):1156. doi: 10.3390/ijms25021156. Int J Mol Sci. 2024. PMID: 38256229 Free PMC article.
-
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy.Front Immunol. 2022 May 18;13:903679. doi: 10.3389/fimmu.2022.903679. eCollection 2022. Front Immunol. 2022. PMID: 35663982 Free PMC article. No abstract available.
-
HDAC3-ERα Selectively Regulates TNF-α-Induced Apoptotic Cell Death in MCF-7 Human Breast Cancer Cells via the p53 Signaling Pathway.Cells. 2020 May 21;9(5):1280. doi: 10.3390/cells9051280. Cells. 2020. PMID: 32455774 Free PMC article.
-
Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer.Sci Rep. 2015 Jul 13;5:10244. doi: 10.1038/srep10244. Sci Rep. 2015. PMID: 26165253 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical